Management of stage III non –small cell lung cancer

Optimal management of patients with locally advanced non –small cell lung cancer remains challenging in the context of this heterogeneous disease. Despite aggressive therapeutic approaches, survival benefits are still unsatisfactory for what might be viewed as a localized malignancy. A combined modality approach offers patients superior outcomes, especi ally because technological advances and refined surgical procedures now provide better results with fewer complications. Nevertheless, several features of therapy remain controversial and lack formal prospective data.

Source: Seminars in Oncology - October 18, 2017 Category: Cancer & Oncology Authors: Samer Tabchi, Elie Kassouf, Elie El Rassy, Hampig Raphael Kourie, Jocelyne Martin, Marie-Pierre Campeau, Mustapha Tehfe, Normand Blais Source Type: research